我们使用cookie改善您的浏览体验并提供有意义的内容。请阅读我们的cookie协议
收藏我们 在线订购 CoA查询
     

机构用户解决方案

产品选择指南

技术服务信息

2.03 
 
Creating Cancer Killers
(runtime: 2:19 min)
 
 
   
     
  The immune system doesn't innately recognize that cancer cells are abnormal, but now researchers can genetically modify a person's own immune cells to attack cancer cells. This type of immunotherapy-a treatment that utilizes the inherent power of the immune system-is increasingly recognized as a promising strategy for the treatment of a variety of cancers. With the help of RetroNectin reagent, Dr. Renier Brentjens reprograms patients' own T cells to recognize a leukemia cell antigen. Returning these engineered cells to patients with relapsed lymphoblastic leukemia can lead to remission. That's Good Science!  
     
     

页面更新:2021-01-20 09:32:52